Cite
HARVARD Citation
Deshmukh, V. et al. (2019). Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment. Osteoarthritis and cartilage. 27 (9), pp. 1347-1360. [Online].